NBY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	487 524
Average Volume	3.64M
Market Cap	2.78M
EPS	$0 ( 2024-04-04 )
Next earnings date	( $-0.300 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0.00100 (1.30%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-09	Freiman Paul E.	Buy	858	Restricted Stock Units
2023-06-09	Garlikov Julie	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yenyou	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yongxiang	Buy	858	Restricted Stock Units
2023-06-09	Sit Swan	Buy	858	Restricted Stock Units

INSIDER POWER
-50.61
Last 96 transactions
Buy: 2 335 940 \| Sell: 2 184 002

Volume Correlation

Long: 0.19 (neutral)

Short: 0.48 (neutral)

Signal:(56.217) Neutral

NovaBay Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NovaBay Pharmaceuticals Correlation - Currency/Commodity

0.00
( neutral )

NovaBay Pharmaceuticals Financials

Annual	2023
Revenue:	$14.73M
Gross Profit:	$7.90M (53.61 %)
EPS:	$-2.29

Q4	2023
Revenue:	$3.73M
Gross Profit:	$1.82M (48.70 %)
EPS:	$-0.370

Q3	2023
Revenue:	$3.26M
Gross Profit:	$1.84M (56.47 %)
EPS:	$-0.370

Q2	2023
Revenue:	$4.61M
Gross Profit:	$2.31M (50.02 %)
EPS:	$-1.270

Financial Reports:

No articles found.

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.